Literature DB >> 11004232

Effects of retinoic acid on airspace development and lung collagen in hyperoxia-exposed newborn rats.

K A Veness-Meehan1, F G Bottone, A D Stiles.   

Abstract

Impaired septal formation and decreased alveolarization are often caused by hyperoxic injury to the developing lung and are characteristic features of bronchopulmonary dysplasia. Dexamethasone, frequently administered to infants during oxygen exposure, also inhibits septal formation in the newborn lung. Vitamin A administration reduces the incidence of bronchopulmonary dysplasia in vitamin A-deficient premature infants, and retinoic acid improves alveolarization in newborn rats treated with dexamethasone, indicating that retinoic acid may be useful in preventing hyperoxia-induced impaired septation in bronchopulmonary dysplasia. To investigate whether treatment with retinoic acid during exposure to hyperoxia would improve septal formation, newborn rats exposed to > or =90% O(2) from d 3 of life to d 14 were treated with retinoic acid (d 3-13 of life) and/or dexamethasone (d 4-13 of life). In contrast with the effects of retinoic acid on dexamethasone-induced inhibition of alveolarization, we found that retinoic acid did not improve septal formation or decrease airspace size in animals exposed to hyperoxia alone or to hyperoxia plus dexamethasone. Retinoic acid did, however, increase collagen in airspace walls as demonstrated by staining and immunohistochemistry. There was no increase in procollagen mRNA by Northern hybridization analysis, indicating that retinoic acid-associated increases in lung collagen are likely due to posttranscriptional regulation. There was a trend toward increased survival in hyperoxia in animals treated with retinoic acid to the extent that combined therapy with retinoic acid and dexamethasone resulted in the greatest improvement in animal survival. These results suggest that although retinoic acid may be of benefit in hyperoxia-induced lung injury and may have important effects on lung matrix, it does not prevent impairment of septation or induce alveolar formation during exposure to hyperoxia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11004232     DOI: 10.1203/00006450-200010000-00004

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  15 in total

Review 1.  Airway and blood vessel interaction during lung development.

Authors:  Alison A Hislop
Journal:  J Anat       Date:  2002-10       Impact factor: 2.610

Review 2.  Inflammatory mediators in the immunobiology of bronchopulmonary dysplasia.

Authors:  Rita M Ryan; Qadeer Ahmed; Satyan Lakshminrusimha
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

Review 3.  Therapeutic potential of growth factors in pulmonary emphysematous condition.

Authors:  Jai Prakash Muyal; Vandana Muyal; Sudhir Kotnala; Dhananjay Kumar; Harsh Bhardwaj
Journal:  Lung       Date:  2012-11-17       Impact factor: 2.584

Review 4.  Is a regenerative approach viable for the treatment of COPD?

Authors:  Matthew Hind; Malcolm Maden
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

5.  Long-term post-pneumonectomy pulmonary adaptation following all-trans-retinoic acid supplementation.

Authors:  Priya Ravikumar; D Merrill Dane; Paul McDonough; Cuneyt Yilmaz; Aaron S Estrera; Connie C W Hsia
Journal:  J Appl Physiol (1985)       Date:  2010-11-25

6.  Bronchopulmonary dysplasia in preterm infants: pathophysiology and management strategies.

Authors:  Carl T D'Angio; William M Maniscalco
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

7.  Melatonin protects against oxidative damage in a neonatal rat model of bronchopulmonary dysplasia.

Authors:  Li Pan; Jian-Hua Fu; Xin-Dong Xue; Wei Xu; Ping Zhou; Bing Wei
Journal:  World J Pediatr       Date:  2009-08-20       Impact factor: 2.764

8.  The calcitriol analogue EB1089 impairs alveolarization and induces localized regions of increased fibroblast density in neonatal rat lung.

Authors:  Angela K Ormerod; Zhenlan Xing; Nancy G Pedigo; Anjali Mishra; David M Kaetzel
Journal:  Exp Lung Res       Date:  2008-05       Impact factor: 2.459

9.  Prevention of bronchopulmonary dysplasia.

Authors:  Matthew M Laughon; P Brian Smith; Carl Bose
Journal:  Semin Fetal Neonatal Med       Date:  2009-09-06       Impact factor: 3.926

Review 10.  Modulation of retinoid signaling: therapeutic opportunities in organ fibrosis and repair.

Authors:  Suya Wang; Jianshi Yu; Maureen A Kane; Alexander R Moise
Journal:  Pharmacol Ther       Date:  2019-10-16       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.